, Volume 21, Issue 4, pp 309–320 | Cite as

Neuroinflammation: beneficial and detrimental effects after traumatic brain injury

  • J. W. Finnie


Traumatic brain injury (TBI) is the major cause of death and severe disability in young adults and infants worldwide and many survivors also have mild to moderate neurological deficits which impair their lives. This review highlights the primary and secondary lesions constituting craniocerebral trauma and the main elements of neuroinflammation, one of the most important secondary events evolving after the initial traumatic insult. Neuroinflammation has dual and opposing roles in outcome after TBI, being both beneficial and harmful, its effects often differing between the acute and more delayed phases after injury. Since each patient with TBI has a unique and complex pattern of cerebral damage, developing pharmacological intervention strategies targeted at the multiple cellular and molecular events in the neuroinflammatory cascade is difficult. While there have been very few successful outcomes to date in human clinical trials of drugs developed to treat TBI in general, those that have been devised to modulate neuroinflammation are discussed.


Traumatic brain injury Neuroinflammation Pharmacotherapeutics 


  1. Aarabi B, Cook J (2005) Missile wounds of the head. In: Reilly PL, Bullock R (eds) Head injury. Pathophysiology and management. Hodder Arnold, London, pp 384–405Google Scholar
  2. Abou-Hamden A, Blumbergs PC, Scott G et al (1997) Axonal injury in falls. J Neurotrauma 14:699–713PubMedGoogle Scholar
  3. Adams JH (1990) Brain damage in fatal non-missile head injury in man. In: Braakman R (ed) Handbook of clinical neurology, vol 13, issue no 57. Elsevier, Amsterdam, pp 43–63Google Scholar
  4. Adams JH (1992) Head injury. In: Adams JH, Ducken LM (eds) Greenfield’s neuropathology. Edward Arnold, London, pp 106–152Google Scholar
  5. Adams JH, Graham DL, Scott G et al (1980a) Brain damage in non-missile head injury. J Clin Pathol 33:1132–1145PubMedGoogle Scholar
  6. Adams JH, Scott G, Parker LS et al (1980b) The contusion index: a quantitative approach to cerebral contusions in head injury. Neuropath Appl Neurobiol 6:319–324Google Scholar
  7. Adams JH, Doyle D, Ford I et al (1989) Diffuse axonal injury in head injury: definition, diagnosis and grading. Histopathology 15:49–59PubMedGoogle Scholar
  8. Adelson PD (1999) Paediatric brain injuries: prognosis and recovery. In: Marion DW (ed) Traumatic brain injury. Thieme, New York, pp 283–290Google Scholar
  9. Aldrich EF, Eisenberg HM, Saydjari C et al (1992) Diffuse brain swelling in severe head-injured children. A report from the NIH traumatic coma data bank. J Neurosurg 76:450–454PubMedGoogle Scholar
  10. Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734–744PubMedGoogle Scholar
  11. American Academy of Paediatrics Committee on Child Abuse and Neglect (1993) Shaken baby syndrome: inflicted cerebral trauma. Pediatrics 92:872–875Google Scholar
  12. Anderson R, McLean J (2005) Biomechanics of closed head injury. In: Reilly PL, Bullock R (eds) Head injury. Pathophysiology and management. Hodder Arnold, London, pp 26–40Google Scholar
  13. Anderson V, Yeates KO (2010) Paediatric traumatic brain injury. Cambridge University Press, Cambridge, pp 1–6Google Scholar
  14. Arvin B, Neville LF, Barone FC et al (1996) The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev 20:445–452PubMedGoogle Scholar
  15. Asensio VC, Campbell IL (1999) Chemokines in the central nervous system: plurifunctional mediators in diverse states. Trends Neurol Sci 22:504–512Google Scholar
  16. Bal-Price A, Brown GC (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia—inhibitory neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 21:6480–6491PubMedGoogle Scholar
  17. Bazan NG, Rodriguez de Torco EB et al (1995) Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J Neurotrauma 12:791–814PubMedGoogle Scholar
  18. Beauchamp K, Mutlak H, Smith WR et al (2008) Pharmacology of traumatic brain injury: where is the “golden bullet”? Mol Med 14:731–740PubMedGoogle Scholar
  19. Bellander BM, Singhrao SK, Ohlsson M et al (2001) Complement activation in the brain after traumatic head injury. J Neurotrauma 18:1295–1311PubMedGoogle Scholar
  20. Biagas KV, Uhl MV, Schiding JK et al (1992) Assessment of post-traumatic polymorphonuclear leucocyte accumulation in rat brain using myeloperoxidase and vinblastine treatment. J Neurotrauma 9:363–371PubMedGoogle Scholar
  21. Blumbergs PC (2005) Pathology. In: Reilly PL, Bullock R (eds) Head injury. Pathophysiology and management. Hodder Arnold, London, pp 41–72Google Scholar
  22. Blumbergs PC, Jones NR, North JB (1989) Diffuse axonal injury in head trauma. J Neurol Neurosurg Psychiatr 52:838–841PubMedGoogle Scholar
  23. Blumbergs PC, Scott G, Manavis J et al (1994) Staining of amyloid precursor protein to study axonal damage in mild head injury. Lancet 344:1055–1056PubMedGoogle Scholar
  24. Blumbergs PC, Scott G, Manavis J et al (1995) Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J Neurotrauma 12:565–572PubMedGoogle Scholar
  25. Blumbergs PC, Reilly PL, Vink R (2008) Trauma. In: Louis DN, Love S, Ellison DW (eds) Greenfield’s neuropathology, vol 1, 8th edn. Arnold, London, pp 733–832Google Scholar
  26. Bradbury MWB (1993) The blood–brain barrier. Exp Physiol 78:453–472PubMedGoogle Scholar
  27. Bullock R, Butcher S, McCullough J (1990) Changes in extracellular glutamate concentration after acute subdural haematoma in the rat—evidence for an “excitotoxic” mechanism. Acta Neurochir (Suppl) 57:274–276Google Scholar
  28. Bullock MR, Lyeh BG, Muizelaar JP (1999) Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 45:207–217PubMedGoogle Scholar
  29. Cederberg D, Siesjo P (2010) What has inflammation to do with traumatic brain injury? Childs Nerv Syst 26:221–226PubMedGoogle Scholar
  30. Chesnut RM, Marshall LF, Klauber MR et al (1993) The role of secondary brain injury in determining outcome from severe head injury. J Trauma 34:216–222PubMedGoogle Scholar
  31. Clark RSB, Kochanek P (2001) Brain injury. Kluwer Academic, BostonGoogle Scholar
  32. Conti AC, Raghupathi R, Trojanowski JQ et al (1988) Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 18:5663–5672Google Scholar
  33. Degos V, Favrais G, Kaindl AM et al (2010) Inflammation processes in perinatal brain damage. J Neural Trans 117:1009–1017Google Scholar
  34. Denny-Brown D, Russell WR (1941) Experimental cerebral concussion. Brain 64:93–164Google Scholar
  35. Donnelly DJ, Popovich PG (2008) Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 209:378–388PubMedGoogle Scholar
  36. Duhaime AC, Gennarelli TA, Thibault LE et al (1987) The shaken baby syndrome: a clinical, pathological, and biomechanical study. J Neurosurg 66:409–415PubMedGoogle Scholar
  37. Finnie JW, Blumbergs PC (2002) Traumatic brain injury. Vet Path 39:679–689Google Scholar
  38. Finnie JW, Blumbergs PC, Manavis J et al (2012) Neuropathological changes in a lamb model of non-accidental head injury (the shaken baby syndrome). J Clin Neurosci 19:1159–1164PubMedGoogle Scholar
  39. Gahm C, Holmin S, Mathiesen T (2000) Temporal profiles and cellular sources of 3 nitric oxide synthetase isoforms in the brain after experimental contusion. Neurosurgery 46:169–177PubMedGoogle Scholar
  40. Garden GA, Moller T (2006) Microglia biology in health and disease. J Neuroimmune Pharmacol 1:127–137PubMedGoogle Scholar
  41. Geddes JF, Hackshaw AK, Vowles GH et al (2001) Neuropathology of inflicted head injury in children. I. Pattern of brain damage. Brain 124:1290–1298PubMedGoogle Scholar
  42. Gehrmann J, Matsumoto Y, Kreutzberg GW (1995) Microglia: intrinsic immuneffector cell of the brain. Brain Res Rev 20:269–287PubMedGoogle Scholar
  43. Gennarelli TA, Thibault LE (1985) Biomechanics of head injury. In: Wilkins RH, Rengachary S (eds) Neurosurgery, vol 2. McGraw-Hill, New York, pp 1531–1535Google Scholar
  44. Gennarelli TA, Spelman GW, Langfitt TW et al (1982a) Influence of the type of intracranial lesion on outcome from severe head injury. J Neurosurg 56:26–32PubMedGoogle Scholar
  45. Gennarelli TA, Thibault LE, Adams JH et al (1982b) Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 12:564–574PubMedGoogle Scholar
  46. Graham DL, Lawrence AE, Adams JH et al (1987) Brain damage in non-missile head injury secondary to high intracranial pressure. Neuropath Appl Neurobiol 13:209–217Google Scholar
  47. Graham DL, Ford L, Adams JH et al (1989a) Fatal head injury in children. J Clin Pathol 42:18–22PubMedGoogle Scholar
  48. Graham DL, Ford L, Adams JH et al (1989b) Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neuosurg Psychiatr 52:346–350Google Scholar
  49. Graham DI, McIntosh TK, Maxwell WL et al (2000) Recent advances in neurotrauma. J Neuropath Exp Neurol 59:641–651PubMedGoogle Scholar
  50. Guilian D, Chen J, Ingeman JE, George JK et al (1989) The role of mononuclear phagocytes in wound healing after traumatic injury to mammalian brain. J Neurosci 9:4416–4429Google Scholar
  51. Hanisch U-K, Kettenmann H (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neurosci 10:1387–1394PubMedGoogle Scholar
  52. Hausmann EH, Berman NE, Wang TT et al (1998) Selective chemokine mRNA expression following brain injury. Brain Res 788:49–59PubMedGoogle Scholar
  53. Hoch RC, Schraufstatter IU, Cochrane CG (1996) In vivo, in vitro and molecular aspects of interleukin-8 and the interleukin-8 receptors. J Lab Clin Med 128:134–145PubMedGoogle Scholar
  54. Holmin S, Mathiesen T (2000) Intracerebral adminstration of interleukin-1β and induction of inflammation, apoptosis and vasogenic oedema. J Neurosurg 92:108–120PubMedGoogle Scholar
  55. Holmin S, Soderlund J, Biberfeld P et al (1998) Intracerebral inflammation after human brain contusion. Neurosurgery 42:291–298PubMedGoogle Scholar
  56. Jaerve A, Muller HW (2012) Chemokines in CNS injury and repair. Cell Tissue Res 349:229–248PubMedGoogle Scholar
  57. Jennett B, Bond M (1975) Assessment of outcome after severe rain damage. Lancet 1:480–484PubMedGoogle Scholar
  58. Jones NR, Blumbergs PC, North JB (1986) Acute subdural haematomas: aetiology, pathology and outcome. Austral NZ J Surg 56:907–913Google Scholar
  59. Juliet PA, Mao X, Del Bigio MR (2008) Pro-inflammatory cytokine production by cultured neonatal rat microglia after exposure to blood products. Brain Res 1210:230–239PubMedGoogle Scholar
  60. Kelley BJ, Lifshitz J, Povlishock JT (2007) Neuroinflammatory responses after experimental diffuse brain injury. J Neuropath Exp Neurol 66:989–1001PubMedGoogle Scholar
  61. Kenne E, Erlandsson A, Lindbom L, Hillered L, Clausen F (2012) Neutrophil depletion reduces oedema formation and tissue loss following traumatic brain injury in mice. J Neuroinflamm 9:17Google Scholar
  62. Kim KS, Wass CA, Cross AS et al (1992) Modulation of blood–brain barrier permeability by tumour necrosis factor and antibodies to tumour necrosis factor in the rat. Lymphokine Cytokine Res 11:293–298PubMedGoogle Scholar
  63. Knoblach SM, Faden AI (1998) Interleukin-10 improves outcome and alters pro-inflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 153:143–151PubMedGoogle Scholar
  64. Kumar A, Loane DJ (2012) Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention. Brain Behav Immun 26:1191–1201PubMedGoogle Scholar
  65. Lenzlinger PM, Morganti-Kossmann MC, Laurer HL et al (2001) The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 24:169–181PubMedGoogle Scholar
  66. Lindenberg R, Freytag E (1960) The mechanism of cerebral contusions. Arch Pathol 69:440–469PubMedGoogle Scholar
  67. Loberg EM, Torvik A (1989) Brain contusions: the time sequence of the histological changes. Med Sci Law 29:109–115PubMedGoogle Scholar
  68. Luerssen TG, Klauber MR, Marshall LF (1988) Outcomes from head injury related to patient’s age: a longitudinal prospective study of adult and paediatric head injury. J Neurosurg 68:409–416PubMedGoogle Scholar
  69. Marshall LE, Gautille T, Klauber MR (1991) The outcome of severe closed head injury. J Neurosurg 75:528–536Google Scholar
  70. Maxwell WL, Povlishok JT, Graham DI (1997) A mechanistic analysis of non-disruptive axonal injury: a review. J Neurotrauma 14:419–440PubMedGoogle Scholar
  71. Mendelow AD, Crawford PJ (2005) Primary and secondary brain injury. In: Reilly PL, Bullock R (eds) Head injury. Pathophysiology and management. Hodder Arnold, London, pp 73–92Google Scholar
  72. Merril JE, Benveniste EN (1996) Cytokines in inflammatory brain lesions. Helpful and harmful. Trends Neurosci 19:331–338Google Scholar
  73. Miller JD, Adams JH (1972) Physiopathology and management of increased intracranial pressure. In: Critchley M, O’Leary J, Jennett B (eds) Scientific foundations of neurology. Heinemann Medical, London, pp 308–324Google Scholar
  74. Morganti-Kossmann MC, Lenzlinger PM, Hans V et al (1997) Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol Psychiatry 2:133–136Google Scholar
  75. Morganti-Kossmann MC, Rancan M, Otto V et al (2001) Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 16:165–177PubMedGoogle Scholar
  76. Morganti-Kossmann MC, Rancan M, Stahel PF et al (2002) Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr Opin Crit Care 8:101–105PubMedGoogle Scholar
  77. Narayan RK, Michel ME, Ansell B et al (2002) Clinical trials in head injury. J Neurotrauma 19:503–557PubMedGoogle Scholar
  78. Norenberg MD, Smith J, Marcillo A (2004) The pathology of human spinal cord injury: defining the problems. J Neurotrauma 21:429–440PubMedGoogle Scholar
  79. Ommaya AK, Gennarelli TA (1974) Cerebral concussion and traumatic unconsciousness. Brain 97:633–654PubMedGoogle Scholar
  80. Povlishock JT (1992) Traumatically induced axonal injury: pathogenesis and pathobiological implications. Brain Pathol 2:1–12PubMedGoogle Scholar
  81. Povlishock JT, Christman CW (1995) The pathobiology of traumatically induced injury in animals and humans: a review of current thoughts. J Neurotrauma 12:555–564PubMedGoogle Scholar
  82. Raghupathi R, Graham DI, McIntosh TK (2000) Apoptosis after traumatic brain injury. J Neurotrauma 17:927–938PubMedGoogle Scholar
  83. Reilly PL, Adams DH, Graham DI, Jennett B (1975) Patients with head injury who talk and die. Lancet 2:375–377PubMedGoogle Scholar
  84. Reinert MM, Bullock R (1999) Clinical trials in head injury. Neurol Res 21:330–338PubMedGoogle Scholar
  85. Rubin LL, Staddon JM (1999) The cell biology of the blood–brain barrier. Ann Rev Neurosci 22:11–28PubMedGoogle Scholar
  86. Scherbel V, Raghupathi R, Nakamura M et al (1999) Differential acute and chronic responses of tumour necrosis factor-deficient mice in experimental brain injury. Proc Natl Acad Sci USA 96:8721–8726PubMedGoogle Scholar
  87. Schmidt OI, Infanger M, Heyde CE, Ertel W, Stahel PF (2004) The role of neuroinflammation in traumatic brain injury. Eur J Trauma 30:135–149Google Scholar
  88. Schwab JM, Seid K, Schluesner HJ (2001) Traumatic brain injury induces prolonged accumulation of cycloxygenase-1 expressing microglia/brain macrophages in rats. J Neurotrauma 18:881–890PubMedGoogle Scholar
  89. Shaw NA (2002) The neurophysiology of concussion. Prog Neuroobiol 67:281–344Google Scholar
  90. Sheriff FE, Bridges LR, Gentleman SM et al (1994) Markers of axonal injury in post-mortem human brains. Acta Neuropathol 88:433–439Google Scholar
  91. Shohami E, Ginis I, Hallenbeck JM (1999) Dual role of tumour necrosis factor-alpha in brain injury. Cytokine Growth Factor Rev 10:119–130PubMedGoogle Scholar
  92. Skaper SD (2011) Ion channels on microglia: therapeutic targets for neuroprotection. CNS Neurol Disord Drug Targ 10:44–56Google Scholar
  93. Soares HD, Hicks RR, Smith DH et al (1995) Inflammatory leucocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J Neurosci 15:8223–8233PubMedGoogle Scholar
  94. Stahel PF, Morganti-Kossmann MC, Kossmann T (1998) The role of the complement system in traumatic brain injury. Brain Res Brain Res Rev 27:243–256PubMedGoogle Scholar
  95. Stoll G, Jander S, Schroeter M (2002) Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. Adv Exp Med Biol 513:87–113PubMedGoogle Scholar
  96. Swartz KR, Liu F, Sewell D (2001) Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 896:86–95PubMedGoogle Scholar
  97. Taoka Y, Okajima K (2000) The role of leucocytes in spinal cord injury in rats. J Neurotrauma 17:219–229PubMedGoogle Scholar
  98. Teasdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81–84PubMedGoogle Scholar
  99. Ward JD (1996) Paediatric head injury. In: Narayan RK, Wilberger JF, Povlishock JT (eds) Neurotrauma. McGraw-Hill, New York, pp 859–867Google Scholar
  100. Watanabe T, Yamamoto T, Abe Y (1999) Differential activation of microglia after experimental spinal cord injury. J Neurotrauma 16:255–265PubMedGoogle Scholar
  101. Zhang J, Rivest S (2001) Anti-inflammatory effects of prostaglandins E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide. J Neurochem 76:855–864PubMedGoogle Scholar
  102. Ziebell JM, Morganti-Kossmann MC (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7:22–30PubMedGoogle Scholar
  103. Zink BJ, Szmydynger-Chodobska J, Chodobski A (2010) Emerging concepts in pathophysiology of traumatic brain injury. Psychiatr Clin N Am 33:741–756Google Scholar

Copyright information

© Springer Basel 2013

Authors and Affiliations

  1. 1.SA Pathology, Hanson Institute Centre for Neurological Diseases and Schools of Medical and Veterinary SciencesUniversity of AdelaideAdelaideAustralia

Personalised recommendations